Why Zymergen Stock Is Plunging 76% Today

·3 min read
Why Zymergen Stock Is Plunging 76% Today

The recently IPO'd synthetic biotechnology start-up ousts its CEO as its only product hits a brick wall.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting